Healthy men test new oral version of edaravone in first human study
NCT ID NCT04481750
First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This early-phase trial tested an oral form of edaravone in 74 healthy adult males to see how safe it is and how the body processes it. Participants received single or multiple doses of the drug or a placebo. The study is complete and focused on gathering basic safety and drug-level information, not on treating any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Edaravone (oral solution or suspension)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigational Site
Osaka, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill help regulate blood sugar? early trial puts PSTC100 to the test
- First human trial launches for experimental PSTB100 drug
- Syringe showdown: does a prefilled device deliver drug as well as a vial?
- Healthy volunteers help unlock the Body's handling of a new drug
- New edaravone tablet tested in healthy volunteers
- Healthy volunteers test new Drug's body processing